{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:10:00Z","timestamp":1733461800918,"version":"3.30.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03580-2","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T07:23:23Z","timestamp":1733383403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the association between hidradenitis suppurativa and malignancy risks: a systematic review"],"prefix":"10.1007","volume":"317","author":[{"given":"Dea","family":"Metko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanti","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muskaan","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"3580_CR1","doi-asserted-by":"publisher","unstructured":"Poli F, Jemec GBE, Revuz J Clinical Presentation. In: Jemec GBE, Revuz J, Leyden JJ, eds. Hidradenitis Suppurativa. Springer. 2006:11\u201324. https:\/\/doi.org\/10.1007\/978-3-540-33101-8_3","DOI":"10.1007\/978-3-540-33101-8_3"},{"issue":"8","key":"3580_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jamadermatol.2020.1422","volume":"156","author":"JM Jung","year":"2020","unstructured":"Jung JM, Lee KH, Kim YJ et al (2020) Assessment of overall and specific Cancer risks in patients with Hidradenitis Suppurativa. JAMA Dermatol 156(8):844\u2013853. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1422","journal-title":"JAMA Dermatol"},{"issue":"5","key":"3580_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ced.13123","volume":"42","author":"S Alkeraye","year":"2017","unstructured":"Alkeraye S, Nguyen T, Le Guern A et al (2017) Mucinous adenocarcinoma in association with hidradenitis suppurativa. Clin Exp Dermatol 42(5):550\u2013551. https:\/\/doi.org\/10.1111\/ced.13123","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"3580_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1308\/003588407X209392","volume":"89","author":"GM Maclean","year":"2007","unstructured":"Maclean GM, Coleman DJ (2007) Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 89(7):709\u2013712. https:\/\/doi.org\/10.1308\/003588407X209392","journal-title":"Ann R Coll Surg Engl"},{"issue":"6","key":"3580_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jdcr.2017.08.017","volume":"3","author":"R Giesey","year":"2017","unstructured":"Giesey R, Delost GR, Honaker J et al (2017) Metastatic squamous cell carcinoma in a patient treated with adalimumab for hidradenitis suppurativa. JAAD Case Rep 3(6):489\u2013491. https:\/\/doi.org\/10.1016\/j.jdcr.2017.08.017","journal-title":"JAAD Case Rep"},{"issue":"1","key":"3580_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/derm.2.1.12490","volume":"2","author":"S Fimmel","year":"2010","unstructured":"Fimmel S, Zouboulis CC (2010) Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2(1):9\u201316. https:\/\/doi.org\/10.4161\/derm.2.1.12490","journal-title":"Dermatoendocrinol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03580-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:21:24Z","timestamp":1733397684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03580-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3580"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03580-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Jensen Yeung has been an advisor, consultant, speaker, and\/or investigator for AbbVie, Allergan, Amgen, Astellas, Arcutis, Bausch Health, Baxalta, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Fresenius Kabi, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Medimmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sun Pharma, Takeda, UCB, and Xenon. Dr. Vincent Piguet has received grants from AbbVie, Bausch Health, Celgene, Eli Lilly, Incyte, Janssen, LEO Pharma, L\u2019Or\u00e9al, Novartis, Organon, Pfizer, Sandoz,, Sanofi and Bristol Myers Squibb; received payment or honoraria for speaking engagement from Sanofi; participated on an advisory board for LEO Pharma, Novartis, Sanofi, Union Therapeutics, Abbvie and UCB; and received equipment donation from L\u2019Or\u00e9al.\u2019","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"68"}}